Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4 | 184649745 | 5 prime UTR variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 184649745 | 5 prime UTR variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 184647083 | intron variant | C/T | snv | 1.7E-04 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
4 | 184646349 | intron variant | T/C | snv | 5.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
4 | 184640236 | intron variant | T/G | snv | 3.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
4 | 184640236 | intron variant | T/G | snv | 3.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
4 | 184634712 | intron variant | A/G | snv | 5.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
4 | 184634471 | intron variant | G/A | snv | 1.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Nervous System Diseases; Mental Disorders | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.790 | 0.200 | 4 | 184632307 | missense variant | C/G | snv | 8.0E-06 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||||
|
0.925 | 0.080 | 4 | 184631944 | splice region variant | T/G | snv | 0.64 | 0.73 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||||
|
0.925 | 0.080 | 4 | 184631944 | splice region variant | T/G | snv | 0.64 | 0.73 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||||
|
0.925 | 0.080 | 4 | 184648576 | 5 prime UTR variant | C/T | snv | 0.11 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.925 | 0.080 | 4 | 184648576 | 5 prime UTR variant | C/T | snv | 0.11 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.790 | 0.200 | 4 | 184628935 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2017 | 2017 |